Chronic Renal Failure clinical trials
31 active trials name this condition. Describe your situation to see which ones you may be eligible for.
Refine by biomarker
By location
- Tolerance Through Mixed Chimerism (Sip-Tego)
- Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
- Structured Program of Exercise for Recipients of Kidney Transplantation
- Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets)
- Delivering Transcutaneous Auricular Neurostimulation to Reduce Blood Loss During Dialysis AV Graft Placement Procedures
- Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD
- SAfety of Regional Citrate Anticoagulation (SARCA Study)
- Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
- Trial of Variable Dialysate Bicarbonate
- CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
- Incremental Hemodialysis: The TwoPlus Trial
- A Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006)
- Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD
- Alirocumab in Patients on a Stable Dialysis Regimen
- Adding Urea to the Final Dialysis Fluid
- A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
- Concordance and Discordance in the Assessment of Volume Status in Home Dialysis Patients: A Comparison of Modified Medical Research Council Dyspnea Scale, Physical Exam, and Point of Care Ultrasound (POCUS)
- Decellularized Femoral Artery Allograft (Nexeon AVX) Prospective Registry
- Simultaneous Prospective Kidney Transplant Assessment in Combined Liver Kidney Candidates
- Repletion of Ergothioneine in Patients With Kidney Failure
- Study of EPN-701 for the Treatment of Calciphylaxis
- Transplantation of Reconstructed Renal Allografts Following Ex-Vivo Partial Nephrectomy
- Adipose-Derived Mesenchymal Stem Cell for Preventing Biliary Complications
- Study of ChoironeX GalKO Porcine Thymokidney Xenotransplantation in End-Stage Renal Disease
- Microvasculature Ultrasound Super-resolution in Transplant Delayed Graft Function
- Anti-Interleukin-6 (IL6) in Calciphylaxis
- Hybrid Dissemination Study of A Digital-Analog Intervention to Increase Live Donor Kidney Transplantation
- Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients
- Feasibility of Intradialytic Monitoring During CKRT
- Goals of Care Conversations Study
- Palliative Care Needs of Children With Rare Diseases and Their Families
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Chronic Renal Failure” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.